References
- Ong KY, Tan TL, Chan AKW, Tan KLL, Koh MS. Managing asthma in the COVID-19 pandemic and current recommendations from professional bodies: a review. J Asthma. 2020:1–8. doi:https://doi.org/10.1080/02770903.2020.1804578.
- Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- Husby A, Pottegaard A, Hviid P. Inhaled corticosteroid use in COVID-19. medRxiv. 2020. doi:https://doi.org/10.1101/2020.09.03.20187278.
- Choi YJ, Park JY, Lee HS, Suh J, Song JY, Byun MK, Cho JH, Kim HJ, Lee J-H, Park J-W, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2020. doi:https://doi.org/10.1183/13993003.02226-2020.
- Calmes D, Graff S, Maes N, Frix A-N, Thys M, Bonhomme O, Berg J, Debruche M, Gester F, Henket M, et al. Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV-2 infection. J Allergy Clin Immunol Pract. 2021;9(1):160–169. doi:https://doi.org/10.1016/j.jaip.2020.09.044.
- Choi JC, Jung S-Y, Yoon UA, You S-H, Kim M-S, Baek MS, Jung J-W, Kim W-Y. Inhaled Corticosteroids and COVID-19 risk and mortality: a nationwide cohort study. J Clin Med. 2020;9(11):3406. doi:https://doi.org/10.3390/jcm9113406.
- Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020;8(9):846–847. doi:https://doi.org/10.1016/S2213-2600(20)30314-3.
- Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, Shimojima M, Fukushi S. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020;95(1):e01648-20. doi:https://doi.org/10.1128/JVI.01648-20.